These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance? Vogt L; Kocks MJ; Laverman GD; Navis G Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515 [TBL] [Abstract][Full Text] [Related]
24. Cyclosporine-induced nephrotoxicity: role of prostaglandins. Jorkasky D; Audet P; Williams S; Grossman R; Conrad M Transplant Proc; 1987 Feb; 19(1 Pt 2):1742-4. PubMed ID: 3079035 [No Abstract] [Full Text] [Related]
25. Early renal pathophysiology in an acute model of cyclosporine nephrotoxicity in rats. Racusen LC; Kone BC; Solez K Ren Fail; 1987; 10(1):29-37. PubMed ID: 3823505 [TBL] [Abstract][Full Text] [Related]
26. Regulation of renal hemodynamics. Hall JE Int Rev Physiol; 1982; 26():243-321. PubMed ID: 6921176 [No Abstract] [Full Text] [Related]
34. Nuclear magnetic resonance and biochemical studies to determine the synergistic detrimental effects of renal ischemia on cyclosporine nephrotoxicity in the rat. Chan L; Suleymanlar G; Malhotra D; Lien YH; Shapiro JI Transplant Proc; 1991 Feb; 23(1 Pt 1):711-3. PubMed ID: 1990660 [No Abstract] [Full Text] [Related]
35. Rifampicin reduces nephrotoxicity of cyclosporine A in rats: studies of renal enzyme excretion. Hopps V; Galione A; Biondi F; Vaccaro F; Sorrentino MC; Vetri P; Leone F Transplant Proc; 1988 Apr; 20(2 Suppl 2):557-60. PubMed ID: 2896405 [No Abstract] [Full Text] [Related]
37. The relative effects of aztreonam versus gentamicin on nephrotoxicity induced by warm ischemia in the presence and absence of cyclosporine. Erturk E; Bretan P; Pestana J; Steinmuller D; Stowe NT; Novick AC Transplant Proc; 1989 Feb; 21(1 Pt 1):932-3. PubMed ID: 2705261 [No Abstract] [Full Text] [Related]
38. Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive? Thiel G; Mihatsch M; Landmann J; Hermle M; Brunner FP; Harder F Transplant Proc; 1985 Aug; 17(4 Suppl 1):169-78. PubMed ID: 3895657 [No Abstract] [Full Text] [Related]
39. Reflections on use of the renal biopsy as the "gold standard" in distinguishing transplant rejection from cyclosporine nephrotoxicity. Solez K; McGraw DJ; Beschorner WE; Kone BC; Racusen LC; Whelton A; Burdick JF Transplant Proc; 1985 Aug; 17(4 Suppl 1):123-33. PubMed ID: 3927535 [No Abstract] [Full Text] [Related]
40. Improvement in renal blood flow and kidney function by modulation of prostaglandin metabolism in cyclosporine-treated animals. Teraoka S; Takahashi K; Tanabe K; Yamaguchi Y; Kawai T; Tojinbara T; Nakajima I; Nakagawa Y; Fujikawa H; Hayashi T Transplant Proc; 1989 Feb; 21(1 Pt 1):937-40. PubMed ID: 2784912 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]